AFT Pharmaceuticals Limited (NZE:AFT)

Revenue by Segment

Financials in millions NZD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	254.71M	208.02M	195.41M	156.64M	130.31M
Total	254.71M	208.02M	195.41M	156.64M	130.31M

Revenue by Geography

Financials in millions NZD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Australia	150.83M	127.10M	108.21M	94.12M	76.67M
New Zealand	59.71M	53.79M	48.72M	44.03M	35.07M
Asia	15.65M	11.09M	10.69M	6.81M	5.49M
International	28.53M	16.04M	27.79M	11.68M	13.09M
Total	254.71M	208.02M	195.41M	156.64M	130.31M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 21, 2026

Data Sources Report a data error